AG真人官方

STOCK TITAN
  1. Home
  2. SEC-Filings
  3. PSNL

Personalis SEC Filings

PSNL NASDAQ

Welcome to our dedicated page for Personalis SEC filings (Ticker: PSNL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Locating the story behind Personalis’ next genomic breakthrough can mean digging through hundreds of pages of SEC text. Our dedicated Personalis filings page turns that task into a focused research session. Start with the Personalis insider trading Form 4 transactions feed to see executive stock moves the moment they post. Curious about the company’s cash runway? The Personalis quarterly earnings report 10-Q filing section lets you jump straight to burn-rate tables, while our AI tags any changes in customer concentration.

Every document鈥�10-K, 10-Q, 8-K, DEF 14A鈥攊s parsed by Stock Titan’s AI engine. Instead of wrestling with dense genomics jargon, you get plain-English call-outs like 鈥渘ew pharma partnership disclosed鈥� or 鈥淩&D expense up 12%.鈥� That means Personalis SEC filings explained simply and ready for quick decision-making.

Need real-time alerts? Enable the Personalis Form 4 insider transactions real-time toggle and get notified before markets open. For deep dives, open the Personalis annual report 10-K simplified view: our AI groups risk factors on reimbursement, CLIA compliance, and intellectual-property challenges so you can scan what matters. You can also:

  • Compare quarter-over-quarter revenue trends with our Personalis earnings report filing analysis
  • Review Personalis proxy statement executive compensation highlights to assess incentive alignment
  • Browse Personalis 8-K material events explained for trial data releases or major contracts
  • Download raw exhibits when you need full context

Whether you’re understanding Personalis SEC documents with AI for a fast pitch deck or tracking Personalis executive stock transactions Form 4 for sentiment signals, this page delivers every filing the instant it hits EDGAR鈥攁lready summarized, already searchable.

Filing

[8-K] Personalis, Inc. Reports Material Event

Rhea-AI Summary
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Personalis (PSNL)?

The current stock price of Personalis (PSNL) is $7.16 as of July 9, 2025.

What is the market cap of Personalis (PSNL)?

The market cap of Personalis (PSNL) is approximately 580.3M.

What core services does Personalis Inc offer?

Personalis provides comprehensive genomic sequencing and data analysis services, supporting research in areas such as personalized cancer immunotherapy, pharmacogenomics, and complex disease studies.

How does Personalis contribute to personalized cancer immunotherapy research?

By leveraging whole genome and exome sequencing along with advanced bioinformatics, Personalis delivers accurate genetic data that supports the development of personalized cancer vaccines and innovative treatment strategies.

What makes Personalis鈥� sequencing services unique?

Their end-to-end approach integrates state-of-the-art laboratory processing, proprietary databases, and sophisticated algorithms, ensuring high precision and actionable insights for genetic research.

Who are the main customers of Personalis Inc?

The company primarily serves academic institutions, pharmaceutical companies, and biotechnology firms that require high-quality genomic data and analysis for research and development.

What is the significance of genome-guided medicine?

Genome-guided medicine involves using detailed genetic information to tailor medical treatments, which enhances the accuracy of diagnoses and the effectiveness of personalized therapies.

How does Personalis ensure the accuracy of its genomic analyses?

The company employs advanced sequencing technologies combined with robust bioinformatic pipelines and proprietary databases, ensuring that data accuracy and reliability are maintained throughout the analytical process.

How does Personalis differentiate itself from other sequencing service providers?

Personalis differentiates itself through its integrated, end-to-end sequencing and analysis model, its focus on both academic research and personalized immunotherapy, and its continual investment in advanced algorithms and data accuracy.

What role does data analysis play in Personalis' operations?

Data analysis is a critical component, transforming raw genomic data into medically relevant insights that drive research in personalized medicine and the development of targeted therapies.
Stock PSNL logo
Personalis

NASDAQ:PSNL

PSNL Rankings

#4914 Ranked by Market Cap
N/A Ranked by Dividends

PSNL Stock Data

580.30M
57.54M
31.34%
42.74%
4.28%
Diagnostics & Research
Services-medical Laboratories
United States
FREMONT